December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Effect of Brimonidine and Dorzolamide, Alone and in Combination, on Aqueous Humor Flow and Intraocular Pressure in Normal Human Eyes
Author Affiliations & Notes
  • H Tsukamoto
    Ophthalmology Hiroshima Univesity School of Medicine Hiroshima Japan
  • H Mishima
    Ophthalmology Hiroshima University School of Medicine Hiroshima Japan
  • E Nuija
    Ophthalmology Uppsala University Hospital Uppsala Sweden
  • Footnotes
    Commercial Relationships   H. Tsukamoto, None; H. Mishima, None; E. Nuija, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3420. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Tsukamoto, H Mishima, E Nuija; The Effect of Brimonidine and Dorzolamide, Alone and in Combination, on Aqueous Humor Flow and Intraocular Pressure in Normal Human Eyes . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3420.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To measure the aqueous humor flow and intraocular pressure (IOP) in human eyes treated with brimonidine and dorzolamide, alone and in combination. Methods: A randomized, double-masked, placebo-controlled study was performed in 20 healthy human subjects. Aqueous humor flow was measured by clearance of fluorescein with a fluorophotometer and IOP with tonometry. Results: Brimonidine, dorzolamide, and the combination of brimonidine and dorzolamide suppressed aqueous humor flow by 28.2% (p<.0001), 19.3% (p<.007) and 37.2% (p<.0001) compared with placebo. The combination of both drugs suppressed aqueous humor flow significantly compared with dorzolamide alone (p<.001) and brimonidine alone (p=.040). Brimonidine, dorzolamide, and the combination of brimonidine and dorzolamide reduced IOP by 11.6% (p<.0001), 8.5% (p=.017) and 17.9% (p=.0003) compared with placebo. The combination of both drugs reduced IOP significantly compared with dorzolamide (p=.0004), but not compared with brimonidine (p=.062). Conclusion: The combination of brimonidine and dorzolamide caused a further reduction in aqueous humor flow compared with each drug applied alone. The IOP was further reduced by the combination when compared with dorzolamide alone, but not with dorzolamide.

Keywords: 324 aqueous • 444 intraocular pressure • 514 pharmacology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×